Proto Labs Inc. has announced a new consulting agreement with former President and CEO, Dr. Robert Bodor, following his departure from the company on May 20, 2025. Under the terms of the agreement, Dr. Bodor will provide transitional consulting services in exchange for a monthly fee of $5,000. The agreement, effective from May 28, 2025, will continue until November 11, 2025, contingent on Dr. Bodor signing a general waiver and release of claims. Additionally, Dr. Bodor is entitled to retain his vested stock options under the company's 2022 Long-Term Incentive Plan, which he can exercise as per the plan's terms until the termination or expiration of the consulting agreement. Any unexercised options will remain exercisable for three months post-termination.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.